The Manufacturers Life Insurance Company Sells 291,726 Shares of Maximus, Inc. $MMS

Posted by George Bondi on Aug 8th, 2026

The Manufacturers Life Insurance Company lowered its stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 85.2% during the first quarter, HoldingsChannel reports. The institutional investor owned 50,540 shares of the health services provider’s stock after selling 291,726 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Maximus were worth $3,240,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC lifted its position in shares of Maximus by 69.0% during the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after acquiring an additional 116 shares during the period. Advisory Services Network LLC bought a new position in shares of Maximus in the third quarter worth $32,000. Canada Pension Plan Investment Board bought a new position in shares of Maximus in the second quarter worth $35,000. Northwestern Mutual Wealth Management Co. raised its stake in Maximus by 225.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 304 shares in the last quarter. Finally, Richardson Financial Services Inc. lifted its position in Maximus by 29.6% during the fourth quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock worth $39,000 after purchasing an additional 103 shares during the period. Institutional investors own 97.21% of the company’s stock.

Maximus News Summary

Here are the key news stories impacting Maximus this week:

Positive Sentiment: Fiscal Q3 adjusted earnings were $2.22 per share, ahead of analyst estimates of approximately $2.20–$2.21 and up from $2.16 a year earlier. Higher margins also supported the quarter’s bottom-line performance. Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
Positive Sentiment: The earnings beat, year-over-year EPS growth and stronger margins indicate that Maximus is maintaining profitability even as sales soften. Maximus Q3 Earnings Beat Estimates
Neutral Sentiment: Management’s fiscal Q3 earnings call focused on the quarterly performance and updated outlook, providing investors with additional context on operating trends and the company’s expectations for the remainder of fiscal 2026. Maximus Q3 2026 Earnings Call Transcript
Negative Sentiment: Revenue was $1.28 billion, below the $1.33 billion consensus estimate and down 5.1% year over year. The shortfall suggests softer demand or project timing is limiting growth. Maximus Fiscal Q3 Earnings Snapshot
Negative Sentiment: Maximus reduced fiscal 2026 EPS guidance to $7.90–$8.20, below the consensus estimate of $8.43. Revenue guidance of $5.2–$5.4 billion remains broadly in line with expectations at the midpoint, but the lower profit outlook is a key overhang for MMS. Updated Maximus Fiscal 2026 Guidance

Analyst Ratings Changes

MMS has been the topic of a number of analyst reports. Zacks Research downgraded shares of Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings downgraded shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Finally, Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a research report on Saturday. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of “Hold”.

Read Our Latest Report on MMS

Maximus Price Performance

Shares of MMS stock opened at $59.21 on Friday. The company has a quick ratio of 2.21, a current ratio of 2.42 and a debt-to-equity ratio of 0.90. Maximus, Inc. has a twelve month low of $52.73 and a twelve month high of $100.00. The company has a market cap of $3.11 billion, a P/E ratio of 8.75 and a beta of 0.59. The business has a fifty day simple moving average of $58.63 and a 200 day simple moving average of $67.46.

Maximus (NYSE:MMS – Get Free Report) last released its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.21 by $0.01. The firm had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The business’s revenue for the quarter was down 5.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, sell-side analysts forecast that Maximus, Inc. will post 8.05 EPS for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Friday, August 14th. Maximus’s dividend payout ratio is currently 19.76%.

Maximus Company Profile

(Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.